Hainan Honz Pharmaceutical Co (300086) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Hainan Honz Pharmaceutical Co (300086) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-9.17 Million ≈ $-1.34 Million USD) by net assets (CN¥1.07 Billion ≈ $157.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hainan Honz Pharmaceutical Co - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Hainan Honz Pharmaceutical Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Hainan Honz Pharmaceutical Co carry for a breakdown of total debt and financial obligations.

Hainan Honz Pharmaceutical Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Honz Pharmaceutical Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ventec International Group Co Ltd TW:6672	-0.028x
First Trust High Yield Opportunities 2027 Term Fund NYSE:FTHY	N/A
Hollyland China Electronics Technology Corp Ltd SHE:002729	0.037x
Johnson Outdoors Inc NASDAQ:JOUT	-0.093x
Gazit Globe Ltd TA:GZT	0.007x
Grid Dynamics Holdings Inc NASDAQ:GDYN	0.013x
Zhejiang Wufangzhai Industry Co. Ltd. A SHG:603237	N/A
Jinsanjiang (Zhaoqing) Silicon Material Company Limited SHE:301059	N/A

Annual Cash Flow Conversion Efficiency for Hainan Honz Pharmaceutical Co (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hainan Honz Pharmaceutical Co from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300086 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.17 Billion ≈ $170.52 Million	CN¥71.46 Million ≈ $10.46 Million	0.061x	+19.53%
2023-12-31	CN¥1.38 Billion ≈ $201.65 Million	CN¥70.69 Million ≈ $10.34 Million	0.051x	+137.15%
2022-12-31	CN¥1.36 Billion ≈ $198.35 Million	CN¥29.32 Million ≈ $4.29 Million	0.022x	+196.65%
2021-12-31	CN¥1.55 Billion ≈ $227.35 Million	CN¥11.33 Million ≈ $1.66 Million	0.007x	+169.76%
2020-12-31	CN¥1.60 Billion ≈ $234.39 Million	CN¥-16.74 Million ≈ $-2.45 Million	-0.010x	-137.16%
2019-12-31	CN¥1.60 Billion ≈ $234.40 Million	CN¥45.06 Million ≈ $6.59 Million	0.028x	-70.50%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥157.66 Million ≈ $23.07 Million	0.095x	+907.72%
2017-12-31	CN¥1.92 Billion ≈ $281.05 Million	CN¥18.17 Million ≈ $2.66 Million	0.009x	-80.51%
2016-12-31	CN¥1.87 Billion ≈ $274.03 Million	CN¥90.88 Million ≈ $13.30 Million	0.049x	+14.15%
2015-12-31	CN¥1.84 Billion ≈ $269.49 Million	CN¥78.30 Million ≈ $11.46 Million	0.043x	+3.78%
2014-12-31	CN¥1.80 Billion ≈ $264.07 Million	CN¥73.93 Million ≈ $10.82 Million	0.041x	-6.05%
2013-12-31	CN¥1.81 Billion ≈ $264.88 Million	CN¥78.93 Million ≈ $11.55 Million	0.044x	-25.37%
2012-12-31	CN¥1.87 Billion ≈ $274.16 Million	CN¥109.46 Million ≈ $16.02 Million	0.058x	+207.30%
2011-12-31	CN¥1.85 Billion ≈ $271.29 Million	CN¥-100.94 Million ≈ $-14.77 Million	-0.054x	-224.62%
2010-12-31	CN¥1.83 Billion ≈ $267.58 Million	CN¥79.89 Million ≈ $11.69 Million	0.044x	-88.77%
2009-12-31	CN¥240.49 Million ≈ $35.19 Million	CN¥93.58 Million ≈ $13.69 Million	0.389x	-6.52%
2008-12-31	CN¥150.41 Million ≈ $22.01 Million	CN¥62.61 Million ≈ $9.16 Million	0.416x	+57.69%
2007-12-31	CN¥115.89 Million ≈ $16.96 Million	CN¥30.59 Million ≈ $4.48 Million	0.264x	--

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic

Market Cap

$492.83 Million

CN¥3.37 Billion CNY

Market Cap Rank

#12612 Global

#3932 in China

Share Price

CN¥7.40

Change (1 day)

+2.49%

52-Week Range

CN¥4.79 - CN¥13.71

All Time High

CN¥17.75